Authors
Latest:
Improving the Traceability of the Clinical Trial Supply ChainOutlining the benefits of using blockchain technology across the supply chain to more securely record and distribute data to sites.
Latest:
CDISC Glossary of Clinical Research TerminologyReference tool is a Rosetta Stone for clinical research. A look at the updates and enhancements in latest version.
Latest:
Demystifying Submissions of eCOA Documentation for Ethics Review: Are We Making Submissions More Difficult than Necessary?Examining how to optimizing the time and effort of Ethics Committees to efficiently and effectively fulfill their human subjects protection remit.
Latest:
CDISC Glossary of Clinical Research TerminologyReference tool is a Rosetta Stone for clinical research. A look at the updates and enhancements in latest version.
Latest:
Positive Changes for Clinical Trials in UkraineThe Ukrainian Government has implemented several important measures to make the country more attractive for clinical trials.
Latest:
Positive Changes for Clinical Trials in UkraineThe Ukrainian Government has implemented several important measures to make the country more attractive for clinical trials.
Latest:
Dermatology Biologics: Overcoming Challenges to Fulfill Therapeutic PotentialTo vie for success in the market for dermatologic therapies, companies developing biologics must navigate a series of significant challenges, including patient compliance and safety.
Latest:
Solving the Data Riddle to Yield Hope for Orphan DiseaseThis article will explore the issues of a lack of data standards; focusing on an industry hackathon that analyzed data sets relating to rare diseases.
Latest:
Metabolomics: Improving the Route from Early Drug Discovery through Clinical DevelopmentMetabolomics can make a positive impact from early drug discovery through clinical development and beyond.
Latest:
Sponsors Ask: Is Our Trial Plan Realistic? Toward a Data-Driven Feasibility AssessmentToday, a data-driven approach to feasibility assessment can help ensure that a sponsor’s clinical research plan is designed to enroll the right patients, rely on the right investigators, and take place in the right countries for success.
Latest:
Optimizing Technology Implementation to Improve Diversity in Clinical ResearchThree key considerations for deploying technology to help increase diversity in trials.
Latest:
Mitigating Risk in Implementing Multi-Regional Trials in MSExamining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
Latest:
Mitigating Risk in Implementing Multi-Regional Trials in MSExamining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
Latest:
Mitigating Risk in Implementing Multi-Regional Trials in MSExamining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
Latest:
Mitigating Risk in Implementing Multi-Regional Trials in MSExamining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
Latest:
Mitigating Risk in Implementing Multi-Regional Trials in MSExamining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
Latest:
Mitigating Risk in Implementing Multi-Regional Trials in MSExamining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
Latest:
Mitigating Risk in Implementing Multi-Regional Trials in MSExamining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
Latest:
Understanding the Investigator Usage of Individual Pharmaceutical Companies; the Pfizer CaseWith Open Payments it is possible for Pfizer to better understand its own investigator usage pattern and how that pattern may differ from the practices of other pharmaceutical companies.
Latest:
Clinical Trials in the Baltic StatesThe region has an appropriate population size, solid infrastructure, experienced nvestigators, and short timelines.
Latest:
Enrollment Cycle Times Can and Should Be OptimizedCase study shows that site activation is a key driver in determining patient enrollment cycle time, which can be minimized by identifying the "sweet spot" of sites to deploy for a clinical trial.
Latest:
A Digital Twin on CAR-T Cytokine Release Syndrome (CRS) Patients with Standard of Care Measured by CRS Distribution by GradeUsing existing clinical trial data to proactively model patient safety and efficacy outcomes could aid in accelerating development for areas in need of new therapies.
Latest:
Enrollment Cycle Times Can and Should Be OptimizedCase study shows that site activation is a key driver in determining patient enrollment cycle time, which can be minimized by identifying the "sweet spot" of sites to deploy for a clinical trial.
Latest:
Build Trust with Honesty and CommunicationThe importance of openness and loyalty cannot be overlooked when cultivating a parternship.
Latest:
Challenges Emerge from Low NASH AwarenessAddressing the current hurdles and potential solutions in nonalcoholic steatohepatitis awareness and clinical trial enrollment.
Latest:
Considering Sex as a Variable in Clinical TrialsA sex-bias that significantly impacts the advancement of women’s health exists in both preclinical and clinical research.
